Amazon cover image
Image from Amazon.com

Management of chemical and biological samples for screening applications / edited by Mark Wigglesworth and Terry Wood.

Contributor(s): Material type: TextTextPublication details: Weinheim : Wiley-VCH, 2012.Description: 1 online resource (xxvi, 406 pages) : illustrationsContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9783527645251
  • 352764525X
  • 9783527645275
  • 3527645276
Subject(s): Genre/Form: Additional physical formats: Print version:: Management of chemical and biological samples for screening applications.DDC classification:
  • 615.1/9 23
LOC classification:
  • RS192 .M36 2012eb
NLM classification:
  • QV 736
Online resources: Summary: "Filling an obvious gap in the scientific literature, this practice-oriented reference is the first to tie together the working knowledge of large screening centers in the pharmaceutical and biotechnological field. It spans the entire field of this emerging discipline, from compound acquisition to collection optimization for specific purposes, to technology and quality control. In so doing, it applies two decades of expertise gathered by several large pharmaceutical companies to current and future challenges in high-throughput screening. With its treatment of libraries of small molecules as well as biobanks containing biomolecules, microorganisms and tissue samples, this reference is universally applicable for any molecular scientist involved in a large screening program."-- Provided by publisher.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Includes bibliographical references and index.

"Filling an obvious gap in the scientific literature, this practice-oriented reference is the first to tie together the working knowledge of large screening centers in the pharmaceutical and biotechnological field. It spans the entire field of this emerging discipline, from compound acquisition to collection optimization for specific purposes, to technology and quality control. In so doing, it applies two decades of expertise gathered by several large pharmaceutical companies to current and future challenges in high-throughput screening. With its treatment of libraries of small molecules as well as biobanks containing biomolecules, microorganisms and tissue samples, this reference is universally applicable for any molecular scientist involved in a large screening program."-- Provided by publisher.

Print version record.

Pharmacy